Motley Fool Premium
  1. Stocks
    2. /
  2. AbCellera Biologics (NASDAQ: ABCL)
    3. /

NASDAQ:ABCL (AbCellera Biologics)

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AbCellera Biologics (NASDAQ: ABCL) Latest News

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    CRA: Here’s the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It

    | Aditya Raghunath

    The CRA confirmed $7,000 in TFSA room for 2026. Here's why AbCellera Biologics could be one of the smartest growth…

    Read more »

    Investing

    The Best Canadian Stock You’ve Never Heard of

    | Aditya Raghunath

    Down over 90% from all-time highs, AbCellera Biologics is a Canadian stock with significant upside potential.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Brian Paradza, CFA

    Canadian biotech stock BELLUS Health has been snatched from the public market. However, these two biopharma growth stocks also have…

    Read more »

    lab worker inspects test tubes
    Investing

    AbCellera Biologics Stock: Here’s What’s Coming in 2023

    | Ambrose O'Callaghan

    AbCellera Biologics Inc. (NASDAQ:ABCL) is a biotech stock that has explosive potential as we wade through the opening month of…

    Read more »

    Piggy bank wrapped in Christmas string lights
    Investing

    Just Released: The 5 Best Stocks to Buy in December 2022 [PREMIUM PICKS]

    | Nate Parmelee (TMFDoraemon)

    Premium content from Motley Fool Stock Advisor Canada “Best Buys Now” Pick #1: AbCellera (NASDAQ:ABCL) AbCellera Biologics (NASDAQ:ABCL) develops antibodies to…

    Read more »